The deck is the investor day presentation GE HealthCare gave on December 8, 2022, ahead of its spin-off from General Electric. It opens with an agenda and a disclaimer, then a catalyst slide and board and leadership introductions. The vision section frames the company's goal of creating a world where healthcare has no limits, followed by its market size, a four-segment leadership overview and a precision care strategy. Each business is then covered in turn: Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics, with segment-specific markets, pipelines and financials. Commercial strategy and a financial strategy section follow, with a recurring revenue split and a medium-term margin bridge. The deck closes with a value creation summary, a closing slide and supplemental non-GAAP material. Slides worth studying include the medium-term financial targets that repeat as a bookend, the segment-by-segment structure with consistent market-size and growth callouts, and the Lean margin bridge. Many slides use a single headline claim with supporting figures in a clean grid.
Slides worth studying



Questions about this deck
How many pages does the GE HealthCare Investor Day presentation have?
The deck has 116 pages. Slide 2 lists the agenda, which runs from opening remarks through segment reviews, financial strategy and closing remarks.
What market size does the GE HealthCare Investor Day deck give for its business?
Slide 13 states a total addressable market of $84 billion in 2021, estimated to reach about $100 billion by 2025. Slide 14 gives industry sizes for 2021 of $44B for Imaging, $12B for Ultrasound, $18B for Patient Care Solutions and $10B for Pharmaceutical Diagnostics.
What are the medium-term financial targets in the GE HealthCare Investor Day deck?
Slide 11 lists mid-single digit organic revenue growth and high-teens to 20% adjusted EBIT margin as medium-term targets, both marked as non-GAAP financial measures. The same targets repeat on slides 12, 17, 26 and 30.
How is the GE HealthCare Investor Day presentation structured?
Slide 2 shows the agenda in order: opening remarks by Larry Culp, vision and strategy by Peter Arduini, then Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics, followed by commercial strategy, a break, financial strategy by Helmut Zodl and closing remarks by Peter Arduini.
Details
- Company: GE HealthCare
- Year: 2022
- Type: Investor presentation
- Industry: Healthcare technology
- Pages: 116
Review score: 7 out of 10, Effective
Presentation quality, judged with the SlideDeck Co review heuristic. Ask, evidence and idea merit are not rated here.
The deck has a clear spine: a recurring three-circle roadmap (slides 11, 12, 17, 26, 30) with progress dots on section slides, and each business repeats the same sequence of at-a-glance tile slide, market chart, strategy and financial summary, then key takeaways. Slides carry one conclusion in a navy banner (13, 16, 28, 95), and the big-number layout on slide 13 and the waterfall on slide 95 read quickly. Weaknesses are consequential: many mid-deck slides are dense with tiny text and thin icons (22, 37 to 42, 62 to 66), the at-a-glance mosaics (35, 49, 60, 71) mix photos and stat tiles in uneven sizes, and the waterfall charts lack data labels on the steps. The roadmap slides use faint grey-out states and small overlapping text in the Driving Growth list on slide 11, and the 116-page length with near-identical roadmap and takeaways pages adds repetition. I only saw 72 of 116 pages, so the later commercial and financial sections are unjudged.
Worth keeping: Keep the repeated roadmap slide with progress dots, the navy takeaway banner on each content slide, and the consistent per-segment sequence that lets an investor compare Imaging, Ultrasound, PCS and PDx.
Most useful repair: Increase text size and thin out the dense pages on 22, 37 to 42 and 62 to 66, fix the cramped line spacing in the Driving Growth list on slide 11, and put values on the waterfall steps on slides 45, 67 and 95.
What would change the score: Cut the at-a-glance mosaics to a cleaner stat row with one consistent image treatment and trim the repeated roadmap and takeaway pages to shorten the deck.
Confidence medium. 72 of 116 pages inspected on contact sheets, 4 at readable size. Reviewed 2026-11-08. Model-assisted review (claude-sonnet-5-5).
Full text of the slides (116 slides)
Every slide's words and a description of its charts and images, so the deck can be searched and rebuilt. Also available as Markdown.
Slide 1
GE HealthCare
GE HealthCare
Investor Day | December 8, 2022
Visuals: Two logo images and one horizontal rule. (1) Top-left logo: the GE monogram in a purple circular roundel followed by the 'GE HealthCare' wordmark in purple, placed at about x 2.1%, y 3.7%, 28.2% by 17.1%, rendered from a 564 by 193 pixel image. (2) Large wordmark: 'GE HealthCare' in a rounded geometric purple sans-serif, placed at about x 7.2%, y 19.6%, 50.1% by 39.0%, rendered from a 685 by 300 pixel image. (3) Rule: a solid purple horizontal bar with rounded ends, spanning from about x 7.9% to 75.8% at about y 49.8%, roughly 0.9% of slide height thick. No charts, photographs or other graphics.
Slide 2
Today’s Agenda
GE HealthCare
Opening Remarks
Larry Culp, Chairman of the Board
Vision & Strategy for Long-Term Value Creation
Peter Arduini, CEO
Imaging
Jan Makela, Imaging CEO
Ultrasound
Roland Rott, Ultrasound CEO
Patient Care Solutions
Thomas Westrick, Patient Care Solutions CEO
Pharmaceutical Diagnostics
Kevin O'Neill, Pharmaceutical Diagnostics CEO
Commercial Strategy and Execution
Catherine Estrampes, U.S. & Canada, CEO
Q&A
Segment Leaders and Peter Arduini
BREAK
Financial Strategy
Helmut Zodl, CFO
Q&A
Peter Arduini and Helmut Zodl
Closing Remarks
Peter Arduini
© 2022, General Electric Company. Proprietary information. All rights reserved.
2
Visuals: Full-bleed purple gradient background image covering the whole slide (no photograph). Logo: GE HealthCare logo at top-right, a white-outlined monogram of the GE mark in a purple circle followed by the white wordmark GE HealthCare in a light sans-serif. Table: 12 alternating semi-transparent light bands (fill #DFC7FC at 10% opacity) on alternate rows, each band 45.8% of slide width per column, with thin white horizontal divider lines between rows. Rows (left column | right column): 1 Opening Remarks | Larry Culp, Chairman of the Board; 2 Vision & Strategy for Long-Term Value Creation | Peter Arduini, CEO; 3 Imaging | Jan Makela, Imaging CEO; 4 Ultrasound | Roland Rott, Ultrasound CEO; 5 Patient Care Solutions | Thomas Westrick, Patient Care Solutions CEO; 6 Pharmaceutical Diagnostics | Kevin O'Neill, Pharmaceutical Diagnostics CEO; 7 Commercial Strategy and Execution | Catherine Estrampes, U.S. & Canada, CEO; 8 Q&A | Segment Leaders and Peter Arduini; 9 BREAK | (empty); 10 Financial Strategy | Helmut Zodl, CFO; 11 Q&A | Peter Arduini and Helmut Zodl; 12 Closing Remarks | Peter Arduini.
Slide 3
Disclaimer
This presentation contains forward-looking statements. These forward-looking statements might be identified by words, and variations of words, such as “will,” “expect,” “may,” “would,” “could,” / “plan,” “believe,” “anticipate,” “intend,” “estimate,” “potential,” “position,” “forecast,” “target,” “outlook,” and similar expressions. These forward-looking statements may include, but are not / limited to, statements about the Company’s expected financial performance and financial condition, including revenue growth, profit, cash flows, and earnings per share and the Company’s 2022 / outlook; taxes; the impacts of macroeconomic and market conditions and volatility on the Company’s business operations, financial results and financial position and on the global supply chain / and world economy; the Company’s strategy, innovation and investments; the Company’s cost structure; the Company’s funding and liquidity; and the impacts of the COVID-19 pandemic. These / forward-looking statements involve risks and uncertainties, many of which are beyond the Company’s control. Factors that could cause our actual results to differ materially from those / described in the Company’s forward-looking statements include, but are not limited to, operating in highly competitive markets; the actions or inactions of third parties with whom the Company / partners and the various collaboration, licensing, and other partnerships and alliances the Company has with third parties; demand for the Company’s products, services, or solutions and factors / that affect that demand; management of the Company’s supply chain and the Company’s ability to cost-effectively secure the materials it needs to operate its business; disruptions in the / Company’s operations; the global COVID-19 pandemic and its effects on the Company’s business; maintenance and protection of the Company’s intellectual property rights; the impact of / potential information technology, cybersecurity or data security breaches; compliance with the various legal, regulatory, tax, and other laws to which the Company is subject and related / changes, claims, or actions; environmental, social, and governance matters; the Company’s ability to successfully complete strategic transactions; the Company’s ability to operate effectively as / an independent, publicly-traded company and achieve the benefits the Company expects from its spin-off from General Electric Company; and the incurrence of substantial indebtedness in / connection with the spin-off and any related effect on the Company’s business. Please also see the "Risk Factors" section of the Company’s Form 10 filed with the U.S. Securities and Exchange / Commission and any updates or amendments it makes in future filings. There may be other factors not presently known to the Company or which it currently considers to be immaterial that / could cause the Company’s actual results to differ materially from those projected in any forward-looking statements the Company makes. The Company does not undertake any obligation to / update or revise its forward-looking statements except as required by applicable law or regulation.
Use of Non-GAAP Financial Measures
In this presentation, we use some information derived from consolidated financial data but not presented in accordance with U.S. generally accepted accounting principles (“GAAP”). These are / considered “non-GAAP financial measures” under SEC rules. These non-GAAP financial measures supplement our disclosures and should not be considered an alternative to the comparable / GAAP measure. Please see the end of this presentation for GAAP to non-GAAP reconciliations including comparable GAAP measures, and please see our Form 10 for more information on the / reasons we use these non-GAAP financial measures.
Financial Comparisons
References to results increasing, decreasing, or remaining flat are in comparison to the same period in the prior fiscal year. Unless stated otherwise, quarterly and annual rates and ranges are / given on an organic basis.
Product Status
Not all products or features are available in all markets. The information presented here may involve technologies and concepts in development that are not products and may never become / products. For Technology in Development, the technologies or concepts are not being offered for sale, and are not cleared or approved by the U.S. FDA or any other global regulator for / commercial availability
© 2022, General Electric Company. Proprietary information. All rights reserved.
3
Visuals: None apart from the GE HealthCare logo at top right: the GE monogram (purple circular emblem with interlaced 'GE' letters) followed by the purple wordmark 'GE HealthCare'.
Slide 4
GE HealthCare
Opening Remarks
Larry Culp
Chairman of the Board
Visuals: Logo only: the GE HealthCare logo, a purple circular monogram with a white stylised GE mark, followed by the purple wordmark 'GE HealthCare' in a light sans-serif. No photograph, chart, or other graphic.
Slide 5
Catalyst Moment
Greater focus and
accountability to
serve patients
and customers
Team alignment ...
dedicated talent,
Board of
Directors,
and investors
Enhanced capital
allocation and
strategic flexibility
© 2022, General Electric Company. Proprietary information. All rights reserved.
5
Visuals: Three photographs in a row, each above a text caption, all boxed at the top of their white cards. Left photo: a female healthcare worker in a white lab coat and light blue surgical mask and blue gloves examining the neck or throat of a woman with curly auburn hair, shown in a striped maroon-and-white top; shallow focus on the clinician, bright clinical lighting, mostly white and warm brown tones. Middle photo: three arrows in flight striking the bullseye centre of a grey target on a dark grey gradient background; arrow fletchings are purple, teal, and green, and the target rings are grey and white. Right photo: a financial stock chart with candlestick bars and a rising line graph on a dark navy background, with glowing orange, red, magenta and cyan-blue light streaks and a blue glow. No axes, labels or values are printed. One GE HealthCare logo: a purple circular monogram with the GE mark, followed by the wordmark 'GE HealthCare' in purple, top-right.
Slide 6
Experienced and Diverse Board of Directors
GE HealthCare
LARRY CULP
Chairman & CEO, GE; / CEO, GE Aerospace
PETER ARDUINI
CEO, GE HealthCare
DR. RODNEY F. / HOCHMAN
President and CEO of / Providence St. Joseph Health
LLOYD W. HOWELL, JR.
CFO and Treasurer of / Booz Allen Hamilton / Holding Company
DR. RISA LAVIZZO- / MOUREY
Former CEO of the Robert / Wood Johnson Foundation
CATHERINE / LESJAK
Former CFO of HP
ANNE T. MADDEN
SVP and General Counsel / of Honeywell International
DR. TOMISLAV / MIHALJEVIC
CEO and President of / Cleveland Clinic
WILLIAM J. STROMBERG
Non-executive Chair / of the Board of / T. Rowe Price Group
PHOEBE L. YANG
Former GM at / Amazon Web Services, / Healthcare
© 2022, General Electric Company. Proprietary information. All rights reserved.
6
Visuals: Ten circular portrait photographs, five in the top row and five in the bottom row, all rendered as blue-tinted monochrome duotone with a soft drop shadow beneath each circle. Top row, left to right: Larry Culp (man, short grey hair, dark suit, smiling, head and shoulders, white shirt); Peter Arduini (man, short hair, smiling, dark jacket over open-collar shirt); Dr. Rodney F. Hochman (man, grey hair, smiling, dark suit and striped tie, darker tone); Lloyd W. Howell, Jr. (man, short dark hair, smiling, dark suit, white shirt); Dr. Risa Lavizzo-Mourey (woman, short curly grey hair, smiling, dark top). Bottom row, left to right: Catherine Lesjak (woman, shoulder-length brown hair, smiling, dark jacket); Anne T. Madden (woman, long wavy blonde hair, neutral expression, black high-neck top); Dr. Tomislav Mihaljevic (man, short grey hair, smiling, dark suit, tie); William J. Stromberg (man, white hair, smiling, dark suit, white shirt); Phoebe L. Yang (woman, shoulder-length dark hair, smiling, white jacket). Each portrait is a head-and-shoulders crop inside a full circle, lit evenly from the front, with a pale blue (#CFE3F5) tint in the light areas and grey-blue shadows. The GE HealthCare logo is a purple monogram roundel with a purple wordmark 'GE HealthCare' to its right, in colour #640ACD on white. No photographs are boxed or cropped to a rectangle.
Slide 7
Highly Qualified Leadership Team Driving Growth
Strong track record of growth, innovation and operational execution
Extensive industry and customer knowledge
Deep experience in healthcare and M&A
Focused Company Driving Precision Care, Well-positioned To Create Significant Value
© 2022, General Electric Company. Proprietary information. All rights reserved.
7
Visuals: Three purple outlined checkmark icons (tick shapes with rounded strokes, colour about #640ACD), one beside each bullet line, at about x 6.6% of the slide width, aligned with the first line of each bullet text. The GE HealthCare logo at top right: a purple circular monogram (GE script inside a ring, about #640ACD) followed by the wordmark 'GE HealthCare' in purple, box x 80.0%, y 4.2%, w 17.0%, h 10.3%. No photographs, charts or tables.
Slide 8
Vision and Strategy for / Long-Term Value Creation / Peter Arduini / CEO
Visuals: One logo: the GE HealthCare logo in the top-left corner, consisting of a purple circular monogram (stylised 'GE' letters in white inside a purple disc) followed by the wordmark 'GE HealthCare' in purple regular-weight sans-serif lettering on one line. No photographs, charts, or diagrams.
Slide 9
GE HealthCare / Create a world where / healthcare has no limits / 9
Visuals: Four photographs stacked in the right column, each a full-width rectangle with hard edges and no overlay or tint. Top photo: a neonatal nurse with a red-blonde ponytail in navy scrubs leans over a clear incubator; a monitor behind shows 37.0; soft neutral beige and white tones. Second photo: a doctor in a white coat with a stethoscope pushes a bed with a patient wearing an oxygen mask under a white blanket, while two nurses in blue scrubs walk alongside; white corridor walls and a glass railing on the right. Third photo: a man in a blue polo and a woman in blue scrubs smile at a wall-mounted ultrasound monitor showing grayscale images, with a cart and keypad below; dark brown wood background. Bottom photo: a smiling man in blue scrubs stands beside a CT gantry, with a patient lying on the bed inside the bore; dark blue tones with a lit corridor at right, cropped at the bottom edge by the slide. Also a purple horizontal rule under the logo, about 0.9% of slide height, rounded ends, colour #640ACD.
Slide 10
Accomplished Leadership Team with Strong Track Record / GE HealthCare / PETER / ARDUINI / CEO / JAN / MAKELA / CEO, Imaging / ROLAND / ROTT / CEO, Ultrasound / TOM / WESTRICK / CEO, PCS / KEVIN / O'NEILL / CEO, PDx / CATHERINE / ESTRAMPES / CEO, USCAN / ROB / WALTON / CEO, EMEA / YIHAO / ZHANG / CEO, China / ELIE / CHAILLOT / CEO, Intercon’tl / HELMUT / ZODL / VP/CFO / BETTY / LARSON / Chief People / Officer / FRANK / JIMENEZ / VP/GC / MIKE / DONOHOE / VP Lean, Chief / Transformation / Officer / LAILA / GURNEY / Chief Quality / & Regulatory / Officer / KEN / STACHERSKI / Chief Integrated / Supply Chain & / Services Officer / ABBY / EPANE-OSUALA / Chief Diversity, / Equity, & Inclusion / Officer / Speaker / © 2022, General Electric Company. Proprietary information. All rights reserved. / 10
Visuals: Fourteen circular headshot portraits, each with a gold-yellow ring (about #F5B800) and a light grey-blue backing circle (#DBE2E9) behind the photo. Row 1 (left to right): Peter Arduini, Jan Makela, Roland Rott, Tom Westrick, Kevin O'Neill, Catherine Estrampes, Rob Walton, Yihao Zhang, Elie Chaillot. Row 2: Helmut Zodl, Betty Larson, Frank Jimenez, Mike Donohoe, Laila Gurney, Ken Stacherski, Abby Epane-Osuala. Each is a head-and-shoulders studio portrait, full face, slightly off-centre, cropped to a circle; plain light grey studio backdrop; soft even frontal lighting; the men wear dark suits or blazers with open-collar or tie shirts; Catherine Estrampes wears a pink top and glasses; Laila Gurney wears a dark top; Abby Epane-Osuala wears a blue jacket. Ring rim is gold with a soft drop shadow. Elie Chaillot, Rob Walton, Yihao Zhang and Peter Arduini have no ring; the other ten have gold rings. The GE HealthCare logo is a purple monogram circle with 'GE' script plus purple wordmark 'GE HealthCare' in sans-serif, about #640ACD. A grey-blue #56718C tab with a gold ring icon and white 'Speaker' text sits at the bottom left, overlapping the purple band edge and the white area below it, with a soft shadow.
Slide 11
Clear Path to Accelerate Long-Term Shareholder Value
Driving Growth
Global Leader
in Attractive,
Growing Market
Executing on
Precision Care
Strategy
Increased
Focus and
Agility
Mid-single digit
Organic Revenue
Growth*
High-teens to 20%
Adj. EBIT Margin*
Strong Free Cash
Flow* Generation
Disciplined Capital
Allocation
*Non-GAAP Financial Measure. Medium-term targets.
© 2022, General Electric Company. Proprietary information. All rights reserved.
11
Visuals: Three filled circles in a left-to-right row, each with a thin concentric broken ring (arc segments) around it: circle 1 slate blue #56718C, circle 2 light cyan #59CBE8, circle 3 navy #002D5D. Each circle holds centred white text. Between circles are black dot-and-line connectors (black dots about 1 percent of width at each circle edge, with a short black horizontal line); after circle 3 a black line runs right to a solid black arrowhead pointing into the purple panel. Right panel holds four white line icons in a column: (1) bar chart with rising trend arrow, (2) pie chart with one slice pulled out, (3) banknote with dollar sign held in a hand, (4) dollar sign with connected nodes on both sides. No photographs. No charts or tables. Decorative light purple #640ACD arcs at 20 percent opacity sit behind the panel and along its left edge, plus a few short diagonal strokes at top right and bottom.
Slide 12
Clear Path to Accelerate Long-Term Shareholder Value
Global Leader
in Attractive,
Growing Market
Executing on
Precision Care
Strategy
Increased
Focus and
Agility
Driving Growth
Mid-single digit
Organic Revenue
Growth*
High-teens to 20%
Adj. EBIT Margin*
Strong Free Cash
Flow* Generation
Disciplined Capital
Allocation
*Non-GAAP Financial Measure. Medium-term targets.
© 2022, General Electric Company. Proprietary information. All rights reserved.
12
Visuals: Three circles: the first is dark slate blue #56718C, the second and third are light blue-grey #BFCBD8, each with white text and thin concentric broken ring arcs in the same colours around its edge (ring arcs are estimated, not measured). Between circles and to the arrow there are four connector images: black filled dots joined by a short black horizontal line, the last ending in a black filled triangular arrowhead pointing right into the panel. Right panel: a large curved shape in #BFCBD8 with a concave left edge, overlaid by about 22 translucent #95A9BE arcs at 20% opacity forming faint curved bands on the left edge. Four white line icons in the panel, top to bottom: a rising bar chart with an upward arrow (bars and arrow in white outline); a pie chart with one wedge pulled out (white outline); a hand holding a phone or banknote with a dollar sign (white outline); a dollar sign connected to four circular nodes by lines (white outline, network style). No photographs; no charts with axes; no logos.
Slide 13
Leader in Attractive, Growing Global Market
$84 billion
› ~$100 billion
Total Addressable Market / in 2021
Estimated by 2025
Global Leader in Attractive, / Growing Market
Global trends:
Aging population
Demand for insights & productivity
Alternative sites of care
Attractive Growth Markets with Potential to Increase TAM With Adjacencies And White Spaces-a)
© 2022, General Electric Company. Proprietary information. All rights reserved.
13
(a - Source: GE HealthCare estimates, drawn from COCIR, NEMA, IPSOS, Signify, BCG, Bain. / Includes radtiotherapeutics, endoscopes, interventional devices and virtual hospital.
Visuals: Three-circle icon cluster top-right: first circle filled slate blue (#5A7390) with concentric thin grey ring outlines, second and third circles light blue-grey (#B8C4D2) with faint concentric rings, sitting inside a white rounded pill with soft shadow; a thin navy connector line drops from the first circle to a horizontal rule with caption 'Global Leader in Attractive, Growing Market'. Center-right: a solid purple (#640ACD) chevron arrow pointing right between the two KPI figures. Three purple (#640ACD) thin-outline circles, each containing a dark-purple checkmark, precede the three trend labels in the lower section.
Slide 14
Leadership Positions in All Four Business Segments / Global Leader in Attractive, / Growing Market / Imaging / Ultrasound / Patient Care / Solutions (PCS) / Pharmaceutical / Diagnostics (PDx) / Industry Size ’21-a) / $44B / $12B / $18B / $10B / Industry CAGR ’22-’25-a) / 4-6% / 4-7% / 3-6% / 4-5% / Attractive End Markets Support Strong Growth Opportunities Across Segments / (a - Based on GE HealthCare estimates and Signify Research for digital solutions / © 2022, General Electric Company. Proprietary information. All rights reserved. / 14
Visuals: Four photographs in a row, each boxed with square corners and no overlay: (1) Imaging, about x 20.2 y 28.8 w 18.3 h 23.1: a white CT scanner gantry and patient table in a bright white room with cyan and magenta LED light strips along the wall and ceiling; cool lighting, dominant white, lavender-grey and magenta. (2) Ultrasound, about x 39.4 y 28.7 w 18.3 h 23.2: a female clinician in navy scrubs with short brown hair pointing at an ultrasound monitor showing a grey scan image, while a patient's leg is in the foreground; soft daylight through a window behind, dominant colours navy, beige and muted green. (3) Patient Care Solutions, about x 58.5 y 28.7 w 18.3 h 23.1: a surgical team in blue caps and masks in an operating room with a surgical light overhead, a monitor and keyboard cart in the foreground; blue-teal tones. (4) Pharmaceutical Diagnostics, about x 77.9 y 28.8 w 18.3 h 22.9: a blue-tinted surgical drape background with four overlaid medical scan images (green brain scan, grey brain scan, purple tissue square, teal heart scan) in a grid; dominant blue and purple. Four circular icon badges, each about 4.9 by 8.8 percent, light grey (#E4E8EE) with soft shadow: imaging badge shows a CT gantry outline in black line art (x 22.0 y 52.7); ultrasound badge shows a wall-mounted device with a probe and cable in black line art (x 40.5 y 52.7); patient care badge shows a heartbeat line in a magnifying glass in black line art (x 58.0 y 52.7); pharmaceutical badge shows a vial or jar in black line art (x 77.4 y 52.7). Decorative top-right element: a white rounded pill (x 81.2 y 3.8 w 18.8 h 9.4) with a soft grey shadow containing three circles; the first is a filled slate blue (#5B7592) ring-shaped circle, the other two are pale blue-grey (#B8C7D6) circles with thin concentric rings. A thin slate line runs from the first circle down to the caption. A light grey-blue band (#DBE2E9 at 62 percent opacity, x 4.2 y 60.8 w 92.0 h 8.4) sits behind the Industry Size row.
Slide 15
GE HealthCare’s Extensive Reach at a Glance
Global Leader in Attractive,
Growing Market
1B+
Patients
served
annually
~$1B
Annual R&D
& product
investment
spend
$18B
Revenue
(~50%
recurring-a)
)
4M+
Installed
base
18.5K
Customer-
facing
employees
42
AI-enabled device
authorizations
in U.S., top of
recent FDA list-b)
Notes: Figures as of 2021 unless otherwise noted
(a - Comprised of services, single-use and consumable products, digital solutions, and value-added offerings, such as education,
training, and consulting
(b - Source: As of October 2022: https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-
machine-learning-aiml-enabled-medical-devices
© 2022, General Electric Company. Proprietary information. All rights reserved.
15
Visuals: Six black outline line icons, each paired with a purple figure: (1) presentation board with a rising arrow and a person, top-left cell; (2) bar chart with a rising trend line, top-centre cell; (3) hand holding a coin with a dollar sign, top-right cell; (4) globe with connected nodes, bottom-left cell; (5) group of three people outlines, bottom-centre cell; (6) award rosette with star and two ribbon tails, bottom-right cell. Stroke is black, about 0.2% of slide height, round-capped. Top-right header pill contains three overlapping circles: the first is a solid slate-blue disc (#5A7090) with concentric thin grey ring outlines, the second and third are pale blue-grey discs (#B8C6D6) with thin rings. Thin navy vertical rules at about x 33.1% and x 62.7%, spanning y 25.8% to 77.9%, and a thin slate horizontal rule at y 50.9% from x 5.5% to 92.9%, colour about #5B6B80, stroke about 0.1% of height. A short navy leader line from the pill down to the caption at x 84.2%, and a short horizontal line under the caption from x 82.2% to 92.9%. The footnote text includes one hyperlink in purple #640ACD underlined.
Slide 16
At the Forefront of Care Delivery Across the Patient Journey
Global Leader in Attractive,
Growing Market
Prevention/Screening
Diagnosis
Treatment
Monitoring
Hospitals | Ambulatory Surgery Centers | Outpatient Clinics | Physicians’ Offices | Home
Improving Patient Outcomes & Customer Productivity With Integrated Products & Installed Base Upgradeability
© 2022, General Electric Company. Proprietary information. All rights reserved.
16
Visuals: Four photographic panels, each containing several product images on white backgrounds, joined by three right-pointing chevron arrows. Panel 1 (Prevention/Screening, left-to-right): a handheld ultrasound probe beside a tablet displaying an ultrasound image with a blue overlay, a tall mammography unit with a white gantry and a grey base, and a white CT scanner with a circular bore. Panel 2 (Diagnosis): a white CT gantry with a circular bore and control panel, a small clear vial with a blue-and-white label, and a tall white ultrasound cart with a black monitor displaying a cardiac scan. Panel 3 (Treatment): a rectangular photo of a surgical operating room with surgeons in blue-green scrubs and masks around a patient, overlapping a circular photo of a white interventional X-ray C-arm over an operating table, the circle with a soft grey shadow. Panel 4 (Monitoring): a circular photo of a clinician in a white coat holding a tablet with a waveform display, beside a stack of white bedside patient monitors showing green, yellow and red waveforms and numeric readouts (60, 98, 60, 120). Logo badge top-right: a rounded white pill containing three circles, the first dark slate blue #5A7391 with concentric rings, the other two pale blue-grey #B8C7D9 with thin rings. Colours are predominantly white, grey and blue-white with small blue and purple accents.
Slide 17
Clear Path to Accelerate Long-Term Shareholder Value
Global Leader
in Attractive,
Growing Market
Executing on
Precision Care
Strategy
Increased
Focus and
Agility
Driving Growth
Mid-single digit
Organic Revenue
Growth*
High-teens to 20%
Adj. EBIT Margin*
Strong Free Cash
Flow* Generation
Disciplined Capital
Allocation
*Non-GAAP Financial Measure. Medium-term targets.
© 2022, General Electric Company. Proprietary information. All rights reserved.
17
Visuals: Diagram: three circles connected in a chain. Circle 1 (left) is light grey #BFCBD8 with white text 'Global Leader in Attractive, Growing Market'. Circle 2 (centre) is cyan #59CBE8 with white text 'Executing on Precision Care Strategy' and is the highlighted step. Circle 3 (right of centre) is light grey #BFCBD8 with white text 'Increased Focus and Agility'. Each circle has a thin outer ring of broken pale grey or cyan arc segments around it. Connectors: a short black line with a filled black dot at each end joins circle 1 to circle 2 and circle 2 to circle 3. A longer black line with a black dot at its start and a black filled arrowhead at its end runs from circle 3 out to the right, ending at the edge of the right panel. Right panel: a large grey #BFCBD8 shape with a convex curved left edge, overlaid by many translucent #95A9BE arc and bar shapes at 20% opacity, and two thin white curved strokes running down the left side of the panel. Four white line icons sit in the panel: a rising bar chart with an upward arrow, a pie chart with one slice pulled out, a hand holding a banknote marked with a dollar sign, and a dollar sign between connected nodes. Their labels are listed under elements.
Slide 18
Precision Care
leverages a patient’s
unique data via
multi-modal sources
to determine the most
appropriate treatment
and deliver the best
possible outcome
Bridging Data and Technology to Deliver
Insights
Multi-modal Data
Images
Pathology
Genomics
Vitals /
Labs
Digital Platform & AI
Patient
Precision
Diagnostics
Precision
Therapy
Precision
Monitoring
© 2022, General Electric Company. Proprietary information. All rights reserved.
18
Visuals: Full-bleed photograph of a clinician’s hands holding and touching a tablet. The tablet screen shows a glowing cyan network and body-outline graphic with small numeric readouts. The photo is cropped to the full slide and tinted blue (#59CBE8) on the right zone; the left zone is covered by a dark translucent panel. Composition: tablet in the upper-middle, fingers pointing at the screen, dark hands and sleeve at the lower-left. Lighting is soft and cool; dominant colours are slate blue and cyan with dark shadows. Diagram, left to right: (1) Four light-cyan (#59CBE8) circles stacked vertically, labelled Images, Pathology, Genomics, and Vitals / Labs, with a rotated bold white label Multi-modal Data running up the left side of the stack. A white bracket (thin line, about 0.2% stroke) joins the stack’s right side to a white chevron pointing right. (2) A white chevron arrow feeds into a central ring: a thin white inner circle with a thin white outer arc, the bold white word Patient in the centre, and the curved bold white label Digital Platform & AI on the upper arc. A second white chevron points right from the ring toward the right stack. (3) A white bracket joins the right side of the lilac stack to the second chevron. Three lilac (#DFC7FC) circles labelled Precision Diagnostics, Precision Therapy, and Precision Monitoring, each with a thin white double arc around it and a small white dot with a short horizontal stub on its left side as a connector. No logos or icons are visible in the render apart from the placed top-right image listed under elements.
Slide 19
Uniquely Positioned to Enable Precision Care
Executing on Precision
Care Strategy
Edison™ Digital
Health Platform
Enterprise
Department
Device
Delivering
Precision Care
Driving productivity
and recurring revenue
Sole Global MedTech Player With Equipment + Digital + Imaging Agents
© 2022, General Electric Company. Proprietary information. All rights reserved.
19
Visuals: Illustration: a circular platform made of a white disc with a soft grey shadow on its lower-right edge, surrounded by a broken double ring of grey (#A4B3BF) arc segments of varying thickness, some thick and some hairline. Inside the disc are three stacked horizontal pill-shaped labels (Enterprise, Department, Device) in front of a vertical purple arrow pointing upward on their left. The arrow runs from the Device level up to the Enterprise level. Gradient wedge: a trapezoid that widens from the circle to the box, fading from near-white (#F4F7FA) at the circle edge to light blue-grey (#D3DCE5) at the box edge, with the top and bottom edges sloping into the box corners. Box: a rectangle outline in light grey-blue (#A4B3BF), about 2 px stroke, white fill, containing the text 'Delivering Precision Care' and 'Driving productivity and recurring revenue'. Icon: a white rounded pill with a soft shadow in the top-right corner holding three circles with fine concentric grey rings: the left and right circles are light grey (#BFC9D3) and the centre circle is solid cyan (#59CBE8) with a cyan ring. A thin cyan vertical line drops from the centre circle to a horizontal cyan line that runs beneath the pill, with the caption below it. Diagram: pill labels stacked vertically, Enterprise at top (purple), Department in the middle (dark grey), Device at the bottom (cyan); each pill is fully rounded with white text. No photographs.
Slide 20
Our / Approach to / Delivering / Precision / Care
D
3
Edison™ digital platform as orchestrator
AI as enabler ...all devices, platform
Oncology
Cardiology
Neurology
Multivendor ecosystem
Executing on Precision / Care Strategy
Smart Devices
Disease States
Digital Platform
Deliver / Precision Care
© 2022, General Electric Company. Proprietary information. All rights reserved.
20
Visuals: Illustration: a concentric ring diagram. Outer dark navy ring (#002D5D) carries curved labels 'Edison™ digital platform as orchestrator' (upper left), 'AI as enabler ...all devices, platform' (upper right) and 'Multivendor ecosystem' (lower left). Middle light blue ring (#5BC8E8) carries curved labels 'Oncology' (top), 'Cardiology' (right) and 'Neurology' (left) in navy. Inner pale grey-blue disc (#BFC9D6) with a purple dotted circular path (#640ACD) ending in a small purple arrowhead at lower centre. Inside the disc are six navy line icons: a patient monitor on a stand (upper left), a software dashboard window with a check badge (upper right), a bedside monitor with wireless signal (left), a CT or MRI gantry (right), a specimen or drug vial (lower left), a mobile C-arm X-ray unit (lower centre), and a magnifier over an ECG waveform (lower right). A small white circle sits at the centre of the disc. Three horizontal chevron bars extend right from the ring: 'Smart Devices' (pale grey #BFC9D6 bar, navy chevron), 'Disease States' (light blue #5BC8E8 bar, navy chevron), 'Digital Platform' (navy #002D5D bar, white chevron). Icon at right panel: black outline document with two check marks and a heart at its lower right corner. Pill-shaped progress tracker at top right: white rounded capsule with three circles, the middle one filled light blue (#5BC8E8) and connected by a thin light blue line to the caption 'Executing on Precision Care Strategy'. Small white circular icon at the centre of the ring.
Slide 21
New Product Introductions Driving Growth / Introduced ~40 New Products at RSNA 2022 / Executing on Precision / Care Strategy / Indicates AI integration / Revolution / Apex / SIGNA™ / (1.5 and 3T) / Omni Legend / (PET / CT) / Portrait / Mobile-a) / Voluson / Expert 22 / CT Motion / Injector / AIR™ / Recon / DL / OEC 3D / End-tidal / Control / Software-a) / Vscan Air / Vivid / Cardiology / Imaging / Ultrasound / Business Segments / Patient Care / Solutions (PCS) / Pharmaceutical / Diagnostics (PDX) / >35% Of Equipment Orders From NPIs In 2021-b) with continued strong growth in 2022 / (a - Portrait Mobile CE marked and 510K pending in US. End-tidal-Control CE marked and FDA approved. / (b - Defined as percentage of product orders received in 2021 in Imaging, Ultrasound and PCS segments for products / introduced in the last 12 months. / © 2022, General Electric Company. Proprietary information. All rights reserved. / 21
Visuals: Twelve product cards, each a white rounded-free rectangle with a soft shadow, holding a product photograph and a name. Row 1: Revolution Apex CT scanner, front view, grey-white, centred, on white background; SIGNA (1.5 and 3T) MRI gantry, white, angled three-quarter view; Omni Legend (PET / CT) scanner, photo with purple-pink lit room, bed extended; Portrait Mobile, grey patient-monitoring module with dark screen showing green numbers, attached cables and electrode pads; Voluson Expert 22 ultrasound cart with dark monitor showing a fetal image. Row 2: CT Motion Injector, blue-and-white stand with two syringes on a mobile base; AIR Recon DL 3D brain MRI slice, grey-white brain on dark blue frame; OEC 3D C-arm system with monitors, white; End-tidal Control Software, photo of clinician in scrubs with monitor in operating room; Vscan Air handheld ultrasound probe beside phone showing colour Doppler image; Vivid Cardiology ultrasound cart with dark screen. Icons: a circular imaging icon, a cart-and-probe ultrasound icon, a magnifier-with-waveform Patient Care icon, and a vial icon for Pharmaceutical Diagnostics. Grey filled stars mark AI-integrated products (SIGNA, Omni Legend, Voluson Expert 22, AIR Recon DL, OEC 3D, Vivid Cardiology). Legend strip shows Imaging icon, Ultrasound icon, Patient Care icon and Pharmaceutical icon. Logos: none.
Slide 22
Care Pathway Strategy Enables Precision Care / Cardiology Example / AI-powered CDS Suite / MAC 2000 / CARESCAPE™ / MyoSPECT / Myoview / Executing on Precision / Care Strategy / RPM Edison™ –a) / Vivid™ / Allia™ IGS / Revolution™ Apex / EARLY DETECTION / EMERGENCY / MONITORING / DIAGNOSIS / INTERVENTION / PLANNING / EDISON™ DIGITAL HEALTH PLATFORM / We Play Across the Care Continuum / Imaging / Patient Care / Solutions (PCS) / Indicates AI integration / Ultrasound / Pharmaceutical / Diagnostics (PDX) / (a- Technology in Development - not a commercial product / © 2022, General Electric Company. Proprietary information. All rights reserved. / 22
Visuals: Central 3D donut-style cycle diagram made of five curved segments around a central elliptical photograph: top purple segment labelled EARLY DETECTION and EMERGENCY (overlapping labels, two lines), left grey-blue segment labelled MONITORING (rotated text), right lavender segment labelled DIAGNOSIS (rotated text), lower-left cyan segment labelled INTERVENTION (rotated text), and lower-right light-cyan segment labelled PLANNING. Each segment has a grey 3D thickness/shadow on its lower edge. Centre: an elliptical photograph of an elderly woman with glasses lying in a white bed and smiling, while a clinician in blue scrubs leans in and holds a stethoscope to her chest; soft natural lighting, cool blue and white tones, subject centred and cropped to an ellipse with a white ring. Around the diagram a thick blue (#0A6EBD) elliptical arc links eight white circular icon badges, each with a navy-outlined ring: AI-powered CDS Suite (imaging icon with grey star), MAC 2000 (patient care icon, magnifier with ECG line), CARESCAPE™ (patient care icon), MyoSPECT Myoview (imaging icon with grey star), RPM Edison™ –a) (ultrasound icon with grey star), Vivid™ (ultrasound icon with grey star), Allia™ IGS (imaging icon with grey star), Revolution™ Apex (imaging icon with grey star). Below the cycle, the words EDISON™ DIGITAL HEALTH PLATFORM are set in a slightly arched bold blue (#0A6EBD) sans-serif, with a small TM superscript after EDISON. Top-right: a rounded white pill containing three circles (grey, cyan highlighted middle, grey) each with a thin ring outline, and a cyan connector line dropping from the middle circle to a horizontal cyan rule with caption text beneath. Legend bottom-left: imaging icon with label Imaging, ultrasound icon with label Ultrasound, magnifier patient care icon with label Patient Care Solutions (PCS), grey star with label Indicates AI integration, pharmaceutical icon (jar/box) with label Pharmaceutical Diagnostics (PDX). Icons are thin navy line art.
Slide 23
Creating an Open / Health Care / Ecosystem with / Integrated / Network Effect
Executing on Precision / Care Strategy
GEHC / Imaging / Fabric
AI/ML / Engine
Third-Party / Vendor & Data / Integration
Edison™ Digital / Health Platform
Development / Platform
Connected / Care / Pathways
Leading / Devices
Open Digital Platform to Drive Better / Insights and Predictive Capabilities
© 2022, General Electric Company. Proprietary information. All rights reserved.
23
Visuals: Hub-and-spoke diagram on a faint grey network mesh. A large central cyan-ringed circle at about x 49% to 61%, y 40% to 62% reads 'Edison™ Digital Health Platform'. Six outer circular nodes sit around it in a ring, each with a thin cyan (#59CBE8) double ring and a black line icon above its label: top-left 'GEHC Imaging Fabric' with a monitor-and-user icon; top-right 'AI/ML Engine' with a brain icon; middle-left 'Third-Party Vendor & Data Integration' with a rising-line-chart-over-table icon; middle-right 'Development Platform' with a browser-window-and-code icon (small image at x 66.7%, y 44.5%, 3.6% by 6.5%); bottom-left 'Connected Care Pathways' with a stethoscope icon; bottom-right 'Leading Devices' with a CT-scanner icon, drawn in navy strokes. Thin grey-blue connector lines link the centre to each node and neighbouring nodes. Background image is a 1536 by 1536 pixel grey network sphere of nodes (grey dots) and light grey lines, spanning x 22.5% to 89.4%, full height, behind the hub. Header: a white rounded pill with a soft drop shadow containing three circles, light grey (#B9C2CE-like) on left, bright cyan (#59CBE8) filled middle with a cyan ring, and light grey on right; a cyan vertical line drops from the middle circle to a horizontal cyan rule under the pill. No photographs.
Slide 24
Higher Commercial and R&D Spend to Drive Growth
Executing on Precision
Care Strategy
Prioritizing Fastest-Growing Areas
Est. CAGR ‘22–‘25
$1B+ 2022E R&D
35%+ NPI vitality-a)
Premium CT / PCCT
~10%-b)
Cardio / 3-D Image-guided Therapies
~15%
Handheld Ultrasound
~20%
Oncology MI / Theranostics
20%+
MR Platforming
~5-7%
AI Solutions and Edison™ Platform
25%+-c)
Driving Organic
Revenue
Growth* &
Adjusted EBIT*
Growing, Focused R&D Driving Innovation Releases Every 12-18 Months-d)
* Non-GAAP Financial Measure
(a - Defined as percentage of product orders received in 2021 in Imaging, Ultrasound and PCS segments for products introduced in the last 12 months.
(b - Premium CT / Photon-Counting CT CAGR pertains to ’18-’30.
(c - Refers to GEHC Edison™ platform and apps revenue growth rate. All other metrics refer to end market growth rates.
(d - For most product lines.
© 2022, General Electric Company. Proprietary information. All rights reserved.
24
Visuals: Two solid purple rectangles on the left (each with a soft drop shadow) carrying white bold text: '$1B+ 2022E R&D' and '35%+ NPI vitality-a)'. A six-row table in the centre with alternating light grey-blue rows (#DBE2E9) for Premium CT, Handheld Ultrasound and MR Platforming, and white rows for Cardio, Oncology and AI Solutions; the column header 'Est. CAGR ‘22–‘25' sits right-aligned above the values column. Rows and values: Premium CT / PCCT ~10%-b); Cardio / 3-D Image-guided Therapies ~15%; Handheld Ultrasound ~20%; Oncology MI / Theranostics 20%+; MR Platforming ~5-7%; AI Solutions and Edison™ Platform 25%+-c). A thin black bracket line runs from the top of the table to the bottom of the table on its right side, with a small solid black chevron arrow pointing right at its midpoint toward the statement. Top-right: a white rounded pill-shaped logo panel with three circles (two grey, one cyan #5BC8E8 highlighted in the centre with a short cyan connector line down to a cyan rule) and the caption 'Executing on Precision Care Strategy'. No photographs.
Slide 25
External Investments to Enhance Precision Care Strategy
Executing on Precision / Care Strategy
ACQUISITIONS
Photon-Counting Tech
Surgical Visualization
Oncology and Neurology
Goal to make treatment / faster and more precise
Expanding into / adjacencies
Capitalizing on / emerging trends
Adding new / capabilities / for customers / and patients
COLLABORATIONS
Radiation Oncology
Precision Oncology
Alternative Care Settings
Pursuing Inorganic Investments to Complement our Leading Portfolio
© 2022, General Electric Company. Proprietary information. All rights reserved.
25
Visuals: Three-step chevron flow: three tinted column panels (cyan #DEF5FA, lavender #DFC7FC, grey #D2D9DF) each holding two white logo/label cards, linked left to right by three dark navy (#0C2340) solid chevron arrows placed between the panels at mid-height. Each white card holds a company logo at its top and a black label beneath. Top-row cards: Prismatic Sensors logo (black wordmark 'Prismatic' with a green square-pixel mark above 'sensors', greyscale/green) labelled 'Photon-Counting Tech'; bk medical logo (green 'bk' with a green sound-wave icon and 'medical' in green, light green accent) labelled 'Surgical Visualization'; ZIONEXA logo (navy stylised 'Z' with 'IONEXA' in navy and a red 'E' accent, with small red text 'CDx Imaging for Oncology') labelled 'Oncology and Neurology'. Bottom-row cards: RaySearch Laboratories logo (dark blue text with grey 'Laboratories' and a grey radiating star-like line graphic) labelled 'Radiation Oncology'; SOPHiA GENETICS logo (dark navy dot-cluster icon with navy text 'SOPHiA GENETICS' and trademark mark) labelled 'Precision Oncology'; AliveCor logo (teal-green 'AliveCor' wordmark with registered mark) above Pursuemore-style Pulsenmore logo (dark red 'Pulsenmore' with a red-grey sound-bar icon) labelled 'Alternative Care Settings'. Row labels 'ACQUISITIONS' (top) and 'COLLABORATIONS' (bottom) run vertically, bold navy, rotated 90 degrees counter-clockwise. Column captions sit between rows: 'Goal to make treatment faster and more precise' in teal, 'Expanding into adjacencies' in purple, 'Capitalizing on emerging trends' in dark grey. A top-right pill-shaped tracker has three circles: left grey, centre bright cyan (#5BC8E8) filled and highlighted with a cyan connector line down to caption 'Executing on Precision Care Strategy', and right grey; the circles have thin concentric grey outlines.
Slide 26
Clear Path to Accelerate Long-Term Shareholder Value / Global Leader / in Attractive, / Growing Market / Executing on / Precision Care / Strategy / Increased / Focus and / Agility / Driving Growth / Mid-single digit / Organic Revenue / Growth* / High-teens to 20% / Adj. EBIT margin* / Strong Free Cash / Flow* Generation / Disciplined Capital / Allocation / *Non-GAAP Financial Measure. Medium-term targets. / © 2022, General Electric Company. Proprietary information. All rights reserved. / 26
Visuals: Three circular nodes in a row, each with a thin concentric broken-arc ring around it (light grey-blue arcs, rounded line ends, approximately 1 pt weight). Circle 1 and circle 2 are light grey-blue #BFCBD8 with white text; circle 3 is dark navy #002D5D with white text, highlighting the final stage. Between circles, black dot-and-line connectors: a dot, a short black horizontal line, then a dot, at the join between circles 1 and 2 and between circles 2 and 3. After circle 3 a black line with a dot at its start ends in a solid black arrowhead pointing right into the grey panel. Right panel: a large light grey-blue #BFCBD8 shape with a curved left edge, overlaid by a set of about 23 translucent #95A9BE shapes at 20% opacity forming soft curved arc bands and stripes behind and across the panel edge, plus a faint decorative arc graphic in the top-right corner. Four white line icons in the right panel, all outlined in white at about 2 pt stroke: (1) a rising bar chart with an upward arrow, aligned with 'Mid-single digit Organic Revenue Growth*'; (2) a pie chart with one wedge pulled out, aligned with 'High-teens to 20% Adj. EBIT margin*'; (3) a hand holding a banknote marked with a dollar sign, aligned with 'Strong Free Cash Flow* Generation'; (4) a dollar sign connected to four circular nodes by lines, aligned with 'Disciplined Capital Allocation'. No photographs; no logos apart from the text copyright line.
Slide 27
Unique Culture Supports our / Priorities for Growth / Building / Our Winning / Culture / Serve Our People, / Patients, & / Customers / Lead with Lean / Empower / Entrepreneurial / Spirit / Deliver The Future / of Healthcare / Win Together / with Inclusive Teams / Positioning our culture to enable success for / our customers, patients and stakeholders / Increased Focus / and Agility / © 2022, General Electric Company. Proprietary information. All rights reserved. / 27
Visuals: Staircase illustration (about 42.8% to 96.3% across, 21.6% to 100% down): five stacked isometric steps rising from lower-right to upper-left, each a parallelogram-topped block with a darker front edge. Step colours from top to bottom: navy, violet, cyan-blue, teal, light cyan, then a grey base step. Each step carries a white-grey (#F2F2F2) teardrop pin with a black line icon, and a thin grey (#BFBFBF) horizontal leader line runs from each label to its step. Icons: (1) open hands cupping a heart; (2) head in profile with a gear and a lightbulb; (3) lightning bolt; (4) hand palm-up holding a speech bubble with a medical cross; (5) three figures with arms raised around a circle. Trophy icon at top-left of the subtitle: a navy (#002C5D) outline trophy with a star on the cup. Pill-shaped progress indicator top-right: white rounded pill with soft shadow containing three circles, the first two pale grey-blue (#C5CED9) and the third navy (#002C5D) with concentric ring detail, with a navy vertical connector and horizontal line leading to the caption 'Increased Focus and Agility'. Background wedge is a soft grey gradient image.
Slide 28
Optimizing our Operating Model as a
Standalone Company
Increased Focus
and Agility
Four Focused & Integrated Segments:
Imaging
Ultrasound
Patient Care
Solutions (PCS)
Pharmaceutical
Diagnostics (PDx)
Enterprise Account Management, Service Delivery
Global Digital Platform
Simplified, Customer-centric Structure Increases Our Speed & Agility
© 2022, General Electric Company. Proprietary information. All rights reserved.
28
Visuals: Four photographs, one per column, each boxed (rectangular, no rounded corners, no overlay). (1) Imaging: a modern CT scanner gantry with a patient table in a clean room with cyan and magenta LED strip lighting along the ceiling and wall; cool lavender-grey floor; wide framing, full image visible. (2) Ultrasound: a woman in navy scrubs holding an ultrasound probe to a patient's knee covered by a grey cloth, while pointing at an ultrasound monitor on a cart; window with blurred autumn trees behind; dominant navy, beige and soft green. (3) Patient Care: an operating room with a surgeon in a blue cap and mask beside a monitor cart, another staff member in blue gown at left, overhead surgical light at top; green-tiled walls; dominant teal, navy and blue. (4) Pharmaceutical Diagnostics: blue-tinted surgical drapes as background with four framed scan images overlaid: a green brain scan at upper left, a colour CT slice at upper right, a purple angiogram square at lower centre and a glowing teal heart scan at lower right; blue overlay tint. Four circular icons (light grey circles with soft drop shadow, dark line icons): an outline of a CT gantry with a person, an ultrasound cart with probe, a magnifier over a heartbeat waveform, and a pill bottle outline. Two thin vertical dark grey rules divide the columns at about x 27.4%, 50.2% and 73.2%, from y 25.2% to 58.9%. Header graphic: three circles, the first two pale grey-blue (#C5CFDC) with thin concentric rings, the third solid navy #002D5D with rings, joined by a navy vertical line to a horizontal navy line beneath it. Four solid navy chevrons (#002D5D): two pointing left at about x 15.9 to 18.0% and two pointing right at about x 84.3 to 86.4%, one pair in each grey bar.
Slide 29
Committed to Enhancing Our ESG Strategy / Five Focus Areas / Access to healthcare / Climate impact & resilience / Circular economy & environmental design / Inclusion & diversity / Cybersecurity & patient data / Environment and Climate / Goal to reduce emissions by 50% by 2030-a) / Net zero by 2050 / Social Capital / 31% of leadership female-b) / 27% ethnically diverse-c) / New Chief DE&I Officer / Governance and Leadership / Enterprise Stewardship Program / Completed materiality assessment / Prioritizing ESG to Support Long-Term Value Creation / (a - Refers to Scope 1 and 2 absolute emissions versus a 2019 baseline. / (b - Leadership encompasses the top 1.5% of all active employees. / (c - Data representative of GE’s U.S. workforce as of December 31, 2021, extracted in January 2022. / © 2022, General Electric Company. Proprietary information. All rights reserved. / 29 / Increased Focus and Agility
Visuals: 1) Navigation pill (top-right): a white rounded pill with soft shadow holding three circles. The first two are light grey-blue circles with thin concentric rings, the third is a solid navy #002D5D circle with concentric rings, and a thin navy leader line runs down from it to the caption Increased Focus and Agility. 2) Left panel: a white rectangle with a 3 pt light cyan #5BC8E8 border and a soft drop shadow, holding five numbered cyan circles (1 to 5) with white bold numerals. 3) Connector: a navy #002D5D thin bracket line (about 0.15% stroke) running from the top of the left panel to the bottom of the grid, with a solid black chevron arrow pointing right at about 36% to 38% of width and 48% to 53% of height. 4) Icons in the grey label cells, drawn in navy #002D5D line art: a globe with meridians and latitude lines (Environment and Climate row, about 42.5% x, 25.8% y, 4.6% w, 6.5% h); a classical building with pediment and columns (Social Capital row, about 42.7% x, 43.5% y, 3.5% w, 5.5% h); a group of three people above a rounded oval (Governance and Leadership row, about 42.3% x, 61.7% y, 4.5% w, 5.0% h). 5) Two placed raster images: one 396 by 444 px at 3.6% x, 21.2% y, 29.7% w, 59.1% h, which appears to be a soft shadow layer behind the left panel, and one 339 by 335 px at 7.6% x, 28.6% y, 25.4% w, 44.5% h, which shows no discernible content at this scale.
Slide 30
Clear Path to Accelerate Long-Term Shareholder Value
Global Leader
in Attractive,
Growing Market
Executing on
Precision Care
Strategy
Increased
Focus and
Agility
Driving Growth
Mid-single digit
Organic Revenue
Growth*
High-teens to 20%
Adj. EBIT Margin*
Strong Free Cash
Flow* Generation
Disciplined Capital
Allocation
*Non-GAAP Financial Measure. Medium-term targets.
© 2022, General Electric Company. Proprietary information. All rights reserved.
30
Visuals: Three filled circles in a left-to-right row, each with an outer ring of thin broken arc strokes in its own colour: circle 1 slate blue-grey #56718C with the word text Global Leader in Attractive, Growing Market; circle 2 light cyan #59CBE8 with Executing on Precision Care Strategy; circle 3 dark navy #002D5D with Increased Focus and Agility. Between circles and after circle 3, black connector lines with solid black dots at each end, the last ending in a solid black arrowhead pointing right into the purple panel. Right panel: a large purple #640ACD shape with a convex curved left edge, overlaid with translucent light-purple arc strokes at 20% opacity. Four white line icons down the panel: (1) at about x 79 to 83, y 40 to 47, a bar chart with an upward arrow; (2) at about x 79 to 83, y 50 to 57, a pie chart with one slice pulled out; (3) at about x 79 to 83, y 61 to 68, a hand holding a banknote marked with a dollar sign; (4) at about x 79 to 83, y 71 to 78, a dollar sign connected by lines to four circular nodes. No chart, table or photograph. A picture box at x 80, y 4.2, w 17, h 10.3 (340 by 116 pixels) sits over the top of the purple panel but shows no visible content in the render.
Slides 31 to 116 continue in the full text file.
Download this deck
The hosted PDF of every library deck is free for readers of the SlideDeck Co newsletter. Join with your email and the viewer and download appear here.
Preparing a results presentation or business update of your own? The SlideDeck Co Standard Deck is a slide library for business reviews, updates and plans.






